Free GIC Executive Briefing to explore COVID-19 vaccines and vaccinations

November 3, 2020

Colleen Murphy, GIC
[email protected]


Free GIC Executive Briefing to explore COVID-19 vaccines and vaccinations

TWEET: Join @interdependence’s next live Executive Briefing on Thursday, November 5 to explore the first heat of COVID-19 vaccines with Dr. Bruce Gellin, M.D. M.P.H., President, Global Immunization at @sabinvaccine. Register with GIC at no cost:



“The Coronavirus Pandemic: The End of the Beginning or the Beginning of the End?” is the theme of this Executive Briefing, as a part of our “Analyzing Pandemics” series. The first heat of COVID-19 vaccines is about to cross the finish line. Is that the beginning of the end or the end of the beginning of the coronavirus pandemic and if you build it, will they come?


  • Bruce Gellin, M.D. M.P.H., President, Global Immunization at the Sabin Vaccine Institute


Thursday, November 5, 2020 | 4:00 – 5:00 p.m. ET


Virtual event held via GoToWebinar




Contact: To register for this event or for more information please contact Colleen Murphy, Manager of Marketing and Communications, at [email protected] or 215-238-0990.

About the Global Interdependence Center: The Global Interdependence Center (GIC) is a Philadelphia-based nonprofit organization that seeks to stimulate thoughtful, global dialogue on a wide range of issues that affect the international community, including economics, health care and government. GIC convenes conferences and roundtable discussions, both domestically and internationally, to identify and address emerging global issues. For more information, visit GIC’s website at

About the Sabin Vaccine Institute: The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non-profit with more than two decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. For more information, visit